Jason Damiano

Jason Damiano is the current Chief Scientific Officer at Appia Bio. Jason has also held the position of Vice President of Biology at UNITY Biotechnology from May 2019 to August 2022. Jason has also worked as a Director of Antibody Therapeutics & In Vivo Pharmacology at Achaogen from March 2016 to September 2018. Jason has also worked as a Cancer biology and biotherapeutics consultant at Biotechnology consulting from October 2018 to April 2019.

Jason Damiano received their PhD in Cellular Pharmacology/Cancer Biology from the University of Arizona. Jason also holds a Bachelor of Science (BS) in Biology from the University of Arizona.

Their manager is JJ Kang, Co-Founder & CEO. Jason Damiano works with Qi Wei - SVP, Technical Operations, Edmund Kim - COO, and Jeff Wiezorek - Chief Medical Officer.